To send content items to your account,
please confirm that you agree to abide by our usage policies.
If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account.
Find out more about sending content to .
To send content items to your Kindle, first ensure firstname.lastname@example.org
is added to your Approved Personal Document E-mail List under your Personal Document Settings
on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part
of your Kindle email address below.
Find out more about sending to your Kindle.
Note you can select to send to either the @free.kindle.com or @kindle.com variations.
‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi.
‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.
This chapter will introduce issues related to management of lipid disorders in older patients to reduce the risk of atherosclerosis and cardiovascular disease (CVD). Because lipid metabolism and regulation do not vary greatly between younger and older people, age-related influences on cardiovascular risk and lipoprotein-mediated disease processes will be our central theme. In addition, aspects of appropriate pharmacotherapy and support of treatment adherence will balance out the overall review.
AGE AND CARDIOVASCULAR RISK
Clinicians typically approach the task of assessing cardiovascular risk by focusing on patient age as an obvious “nonmodifiable risk factor.” The Framingham risk score estimates 10-year absolute risk for CVD events and age contributes enormously to the end result, given that indeed age is the greatest contributor to absolute cardiovascular risk. This may be related to the multiple observations that have concluded atherosclerosis as a process that begins early in life. Advanced age reflects an increased duration of exposure to various risk factors and an accumulation of coronary disease burden. The Framingham Risk Score is less robust in the elderly (age >70 years) as this group has already had their “age-based” exposure. A comparison of the risk factor counting method as outlined in the National Cholesterol Education Program Guidelines to a multivariate analysis demonstrated that these guidelines underestimate risk among more than 5 million persons with fewer than two risk factors. Compared to individuals whose classification was unchanged, those misclassified as low risk were older and more likely to be male.
Email your librarian or administrator to recommend adding this to your organisation's collection.